News Category
VERAXA Biotech is implementing FDA-aligned New Approach Methodologies to accelerate preclinical development, cut costs, and significantly reduce anima...
Lantern Pharma receives Taiwan regulatory and IRB approvals to open Part 2 of its Phase 2 HARMONIC trial, potentially accelerating development of LP-3...
VERAXA Biotech (NASDAQ: VRXA) is implementing FDA-aligned New Approach Methodologies to reduce animal testing, potentially accelerating clinical advan...
A new study reveals lymph node-like structures in the skull that could enable localized immune responses against brain diseases, potentially transform...
GeoVax's next-generation MVA-X vaccine demonstrated durable single-dose protection against lethal mpox, including Clade I, and durable CD8+ T-cell res...
Onco-Innovations is integrating manufacturing, preclinical, and regulatory activities for its lead cancer candidate ONC010, aiming to move it toward f...
Experts emphasize that asking about clinical trials at the first appointment can open doors to promising new treatments and better quality of life for...
Telomir Pharmaceuticals reports that its lead compound Telomir-Zn inhibited growth in human and canine osteosarcoma cell lines at similar low concentr...
The Dr. Wael Sakr Scholarship for Medical Students offers a one-time $1,000 award to undergraduate pre-med students, aiming to ease financial burdens ...
Creative Biolabs has upgraded its single-cell multi-omics and RNA sequencing services to meet growing demand for high-resolution cellular profiling, e...
A new review reveals that the tumor microenvironment actively sculpts natural killer cells into distinct subsets with specialized functions, offering ...
The September 17 Life Sciences Virtual Investor Forum will feature seven companies developing therapies in oncology, fibrosis, drug delivery, antibiot...
VERAXA Biotech's appointment of Dr. Christoph Erkel as CSO signals a strategic push to advance its BiTAC® T-cell engager and broader oncology pipeline...
Quantum BioPharma's Lucid-MS, a first-in-class PAD2 inhibitor, has received FDA clearance to begin a Phase 2 trial in multiple sclerosis, potentially ...
Onco-Innovations' CMO Dr. Islam Mohamed detailed the company's novel PNKP-targeting drug candidate ONC010 on the BioMedWire podcast, emphasizing its p...
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, is moving toward a Phase 2 trial for multiple sclerosis following FDA clea...
Kairos Pharma's CEO will present at the H.C. Wainwright conference, underscoring the company's innovative approach to tackling cancer drug resistance ...
GeoVax supports the new global mpox vaccine stockpile and emphasizes its GEO-MVA candidate's readiness to bolster diversified vaccine supply.
VERAXA Biotech's appointment of seasoned financial executive Raju Willener as CFO underscores its commitment to advancing its BiTAC platform and oncol...
Onco-Innovations advances its oncology pipeline by building manufacturing capabilities, IND-enabling activities, and capital foundation ahead of plann...
Quantum BioPharma's FDA clearance for Lucid-MS, a first-in-class remyelinating agent, marks a pivotal step toward a treatment that could potentially r...
OS Animal Health, a subsidiary of OS Therapies, will present its lead candidate OST-HER2 for canine osteosarcoma at the 2026 Disruptive Growth & Life ...
A study from Washington University School of Medicine highlights the growing role of laser interstitial thermal therapy (LITT) in brain cancer treatme...
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS, a first-in-class myelin repair candidate, could challenge the current treatment par...
NanoViricides has registered its Phase II Ebola trial for NV-387 Oral Gummies in the Pan African Clinical Trials Registry, marking a critical step in ...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials for multiple sclerosis marks a pivotal step toward a targeted therapy that c...
Recent FDA data show youth tobacco use at historic lows, while FDA's modified risk orders for ZYN nicotine pouches provide adult smokers with scientif...
A new study reveals that the timing of brain metastasis development in colorectal cancer patients significantly impacts survival, highlighting the nee...
Onco-Innovations' ONC010 progresses through key preclinical milestones, including high-purity API production and a novel catalyst, positioning it for ...
VERAXA Biotech's appointment of seasoned financial executive Raju Willener as CFO signals a strategic move to strengthen its capital markets position ...
OS Therapies' participation at the Moody Capital Solutions conference underscores its strategic positioning ahead of pivotal regulatory decisions and ...
A Swiss preclinical study reveals that administering immunotherapy prior to surgical removal of glioblastoma tumors significantly improves treatment o...
New research from Mass General Brigham reveals that unintended radiation exposure to the thymus during lung cancer treatment is linked to worse clinic...
Dr. Salman Fazal's 2026 Castle Connolly Top Doctor honor highlights his pioneering work in stem cell transplantation and cellular therapies, underscor...
NanoViricides is progressing its measles treatment NV-387 toward Phase II clinical trials, leveraging FDA designations and promising preclinical data,...
TransCode Therapeutics announced preclinical results showing its lead candidate TTX-MC138 significantly improves survival in a breast cancer bone meta...
A new educational initiative highlights the importance of PSMA PET scans in guiding prostate cancer treatment, with insights from experts and a patien...
A nurse's battle with metastatic triple-negative breast cancer underscores the significance of newer ADC therapies and the need for patients to ask in...
Heidelberg Pharma and Huadong Medicine have received NMPA approval to conduct a Phase Ib/II trial of HDP-101 in combination therapies for relapsed/ref...
A new study validates VolitionRx's Nu.Q NETs H3.1 biomarker as an independent predictor of mortality and renal replacement therapy need in sepsis pati...
Novogenia's U.S. launch of the MGT Plus methylation test, covering 27 genes across six biological pathways, marks a significant expansion in personali...
Citius Pharmaceuticals' commercial launch of LYMPHIR and promising late-stage pipeline position it as a key player in critical-care oncology.
Annovis Bio announced a corporate update webinar to discuss its pivotal Phase 3 Alzheimer's trial and other key milestones, underscoring its progress ...
A new study suggests that a personalized mRNA vaccine derived from a patient's tumor can prevent melanoma recurrence for years, offering hope for dura...
Creative Biolabs announces an exclusive webinar on modeling T cell dysfunction in the tumor microenvironment, highlighting the importance of understan...
Dr. David Zelby, a Marietta prosthodontist with over 40 years of experience, has been recognized as a Castle Connolly Top Dentist, an honor reflecting...
A novel T cell therapy shows promise in treating recurrent glioblastoma, offering hope for a disease with limited options.
VERAXA Biotech and Secarna's collaborative AOC candidate shows greater potency in early in vitro studies, validating the approach for autoimmune disea...
